We serve Chemical Name:Parishin D CAS:952068-64-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Parishin D
CAS.NO:952068-64-3
Synonyms:1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,3-bis[(4-hydroxyphenyl)methyl] ester;2-Hydroxy-4-[(4-hydroxybenzyl)oxy]-2-{2-[(4-hydroxybenzyl)oxy]-2-oxoethyl}-4-oxobutanoic acid
Molecular Formula:C20H20O9
Molecular Weight:404.367
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:685.3±55.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.626
PSA:150.59000
Exact Mass:404.110718
LogP:2.06
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,3-bis[(4-hydroxyphenyl)methyl] ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Hydroxy-4-[(4-hydroxybenzyl)oxy]-2-{2-[(4-hydroxybenzyl)oxy]-2-oxoethyl}-4-oxobutanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,3-bis[(4-hydroxyphenyl)methyl] ester Use and application,2-Hydroxy-4-[(4-hydroxybenzyl)oxy]-2-{2-[(4-hydroxybenzyl)oxy]-2-oxoethyl}-4-oxobutanoic acid technical grade,usp/ep/jp grade.
Related News: Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday��s guideline said. Parishin D manufacturer The CTSuccess service uses Catalent��s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics. Parishin D supplier The CTSuccess service uses Catalent��s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics. Parishin D vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. Parishin D factory Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday��s guideline said.
